Life Science REIT PLC (LABS) — Capital Reinvestment Ratio
Life Science REIT PLC (LABS) has a Capital Reinvestment Ratio of 6.06x as of June 2025, meaning it reinvests 6% of its operating cash flow (GBX958.00K) in capital expenditures (GBX5.81 Million). See net asset quality index of Life Science REIT PLC to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Life Science REIT PLC Capital Reinvestment Ratio (2021–2024)
This chart tracks Life Science REIT PLC's Capital Reinvestment Ratio across 3 annual periods. Check Life Science REIT PLC cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Life Science REIT PLC (2021–2024)
Year-by-year Capital Reinvestment Ratio for Life Science REIT PLC from 2021 to 2024. For live market cap and broader valuation context, see LABS stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (GBX) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.49x | GBX12.92 Million | GBX19.28 Million | ▼ -52.7% |
| 2023 | 3.16x | GBX7.62 Million | GBX24.03 Million | ▲ +46.1% |
| 2021 | 2.16x | GBX3.54 Million | GBX7.64 Million | — |